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Abstract
Background: Proximal humeral fractures are common in older patients. The majority are minimally displaced and
are associated with good outcomes after nonoperative treatment. Poorer outcomes are associated with displaced,
multipart fractures. There is no clear benefit from surgical fracture fixation compared to nonoperative treatment.
Replacement of the fractured humeral head with a hemiarthroplasty is another treatment option, but has not been
shown to be clearly superior to nonoperative treatment or internal fixation. Recently, reverse total shoulder arthroplasty
has been used to treat these fractures, particularly in the older population with several case series demonstrating good
outcomes. No comparative trial has been performed to test the effectiveness of reverse total shoulder arthroplasty
against nonoperative treatment.
Methods/design: ReShAPE (Reverse Shoulder Arthroplasty for the treatment of Proximal humeral fractures in
the Elderly) is a multicenter combined randomized and observational study. The primary objective is to compare
pain and function 12 months post fracture using the American Shoulder and Elbow Society (ASES) score in patients
aged 70 years or older with three- and four-part proximal humeral fractures treated by either reverse shoulder
arthroplasty or nonoperative treatment. Secondary outcome measures will include the DASH (Disability of the
Arm, Shoulder and Hand) score, the EQ-5D (EuroQol Health Survey), the EQ-VAS, pain, radiological parameters
and complications.
Discussion: The study will assess the effectiveness of reverse shoulder arthroplasty for complex proximal
humeral fractures and thereby guide treatment of a common injury in the older population.
Trial registration: World Health Organization Universal Trial Number (WHO UTN): U1111-1180-5452. Registered
on 10 March 2016.
Australian and New Zealand Clinical Trials Registry (ANZCTR): 12616000345482. Registered on 16 March 2016.
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Background
Humeral neck fractures account for 5% of fractures of the
appendicular skeleton [1] and are the third commonest
osteoporotic fracture [2] occurring with an incidence of
6.6 per 1000 person years [3]. There is a unipolar age dis-
tribution with most occurring in the older independent
population with osteoporosis who fall from a standing
height [4]. This incidence is set to increase in the next
20 years as a result of population growth and an aging
population [5]. Forty-nine to 85% of proximal humeral
fractures are minimally displaced and are usually treated
nonoperatively with most having a good outcome regard-
less of comminution [4, 6, 7]. The poorer outcomes asso-
ciated with displaced, multipart fractures has led surgeons
to investigate operative alternatives [3, 8, 9]. Internal fix-
ation with locking plates, which have some advantages in
osteoporotic bone, have been subject to randomized trials,
but have not been shown to improve outcome over non-
operative treatment [10–13]. Replacement of the fractured
humeral head (hemiarthroplasty) is another treatment op-
tion, but has not been shown to be clearly superior to
nonoperative treatment or plate fixation [14, 15].
Recently, reverse total shoulder arthroplasty has been
used to treat these fractures, with several case series
published [16–20]. This prosthetic design negates the ef-
fects of tuberosity malunion and nonunion that are
common after internal fixation or hemiarthroplasty by
creating a mechanical advantage for the deltoid muscle
to allow active forward elevation and abduction. Studies
comparing reverse total shoulder arthroplasty to hemiar-
throplasty for the treatment of proximal humeral frac-
tures have shown improved pain scores and functional
outcomes after reverse shoulder arthroplasty [21, 22].
The use of reverse shoulder arthroplasty for the treat-
ment of proximal humeral fractures is increasing [23].
Reverse shoulder arthroplasty has been reported to have
a high complication rate including instability, loosening,
poor rotation and radiological notching [24]. The risk of
complications and prosthetic longevity limits the use of
reverse shoulder arthroplasty in young patients with




We aim to test the hypothesis that in patients aged 70 years
and over with three- or four-part fractures of the humeral
neck, treatment with reverse total shoulder arthroplasty
will result in improved shoulder pain and function 2 years
post injury compared to nonoperative treatment.
Study design
The study is a combined multicenter randomized con-
trolled trial (RCT) combined with an observational
cohort study. Eleven centers in Australia will participate.
The study Consolidated Standards of Reporting Trials
(CONSORT) flowchart is provided in Fig. 1. The SPIRIT
Checklist is provided in Additional file 1 and the Stand-
ard Protocol Items: Recommendations for Interventional
Trials (SPIRIT) diagram is provided in Fig. 2
Ethics
The recruiting sites in alphabetical order are: The
Canberra Hospital, Concord Hospital, Gosford Hospital,
John Hunter Hospital, Liverpool Hospital, Prince of Wales
Hospital, Royal North Shore Hospital, Royal Prince Alfred
Hospital, St. George Hospital, Sutherland Hospital and
Westmead Hospital.
The study is registered with the Australasian and New
Zealand Clinical Trials Registry (12616000345482) and
the World Health Organization Universal Trail Registry
(U1111-1180-5452)
Study population
Patients will be considered for the study if they are
70 years of age or older, medically fit for surgery, have a
three- or four-part proximal humerus fracture according
to Neer’s classification [6] (Table 1), present within
28 days after injury, and are available for follow-up for
24 months.
Patients will be excluded if they are unable to provide
consent due to limited proficiency in English or cogni-
tive impairment (three or more errors on the Mini Men-
tal Status Examination 6-item screening tool) [26], live
in a residential aged care facility, have a pre-existing in-
jury or condition of the affected side which severely
affects the movement of the shoulder, a pathological
fracture, other injury to the same upper limb requiring
surgery, an open fracture, a fracture-dislocation or head-
splitting fracture, a glenoid fracture, gross fracture dis-
placement (no bony contact between humeral shaft and
articular segment) or an axillary nerve palsy.
Recruitment
Patients will be approached on presentation to a partici-
pating institution either in the emergency department or
in the outpatient setting. Patients aged 70 years and over
with a displaced proximal humerus fracture with tuber-
osity involvement will undergo a computed tomography
(CT) scan with 3D reconstructions to assess the fracture
configuration and to assess the number of fracture parts
according to Neer’s classification [6] (Table 1). Linear
measurements will be made with digital calipers. The
normal neck shaft angle will be assumed to be 130°. Ver-
bal consent will be requested to allow questioning to
assess eligibility and to collect identifiable data. The frac-
ture type will be screened against the inclusion criteria
by two of the principal investigators. Patients who satisfy
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the study criteria will be invited to participate in the
study and will receive a Participant Information Sheet
(see Additional file 1). Patients who are willing to par-
ticipate in the randomized trial will be asked to sign a
Consent Form. Basic demographic and radiographic data
will be collected for both groups to assess independent
variables (age, gender, fracture type, diabetes (yes/no),
smoking status (current/non), baseline shoulder function
(American Shoulder and Elbow Society (ASES) score,
Disability of the Arm, Shoulder and Hand (DASH)
score) and baseline health (EuroQol Health Survey 5 di-
mensions (EQ-5D) and EuroQol Visual Analog Scale
(EQ-VAS)). Patients who are unwilling to participate in
the randomized trial will be offered participation in the
observational study and will be provided with a separate
Participant Information Sheet and Consent Form.
Randomization
Randomization will occur immediately after consent has
been gained. Randomization will occur by using a
central, telephone-based automated randomization ser-
vice with each site having its own access code (provided
by the NHMRC Clinical Trials Center). Randomization
will be stratified by site and will use minimization to ad-
just for gender and age (70–80 years, over 80 years).
Interventions
Participants who are randomized to surgery will be
treated by insertion of a reverse total shoulder arthroplasty
within 28 days of the date of injury. Surgical technique
(approach, version, component fixation and prosthesis
choice) will be left to the discretion of the treating
surgeon. The glenosphere will be placed low, avoiding su-
perior tilt. The tuberosities will be repaired using nonab-
sorbable sutures. Postoperatively, the arm will be placed in
a shoulder immobilizer and patients will be instructed on
elbow, wrist and hand exercises to commence immedi-
ately. Two weeks postoperatively, pendular exercises and
passive flexion to 90° and passive external rotation to neu-
tral will be commenced. Unrestricted passive and active
Fig. 1 Consolidated Standards of Reporting Trials (CONSORT) flowchart
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assisted exercises will be allowed, graduating to active
mobilization (as tolerated) at 6 weeks post surgery.
Resisted range of motion exercises will be allowed after
12 weeks. A minimum of five physiotherapy contacts
within 3 months of treatment will be provided.
Patients randomized to nonoperative treatment will
be placed in a shoulder immobilizer. Elbow wrist and
hand exercises will be allowed immediately. After
2 weeks, pendular exercises and passive flexion to 90°
and passive external rotation to neutral will be com-
menced. Unrestricted passive and active assisted exer-
cises will be allowed graduating to active mobilization
(as tolerated) at 6 weeks. Resisted range of motion
exercises will be allowed after 12 weeks. A minimum
of five physiotherapy contacts within 3 months of
treatment will be provided.
Parallel observational cohort study
Patients who do not consent to be randomized will be
offered participation in the observational arm of the
study. Their treatment will consist of the same two treat-
ment options as the RCT arm. Treatment will be de-
cided by patient and surgeon preference as per usual
practice at each institution. Treatment protocols, follow-
up and outcome measures will be the same as the ran-
domized arm. The outcome of this arm of the trial will
be analyzed separately. The inclusion of the observa-
tional cohort will inform the generalizability of the ran-
domized trial.
Fig. 2 Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) diagram
Table 1 Neer’s classification of proximal humeral fractures and
radiological inclusion criteria
Potential fracture “parts” (Neer) Head (H), Shaft (S), Lesser tuberosity(LT),
Greater tuberosity (GT)
Definition of a “part” (Neer) >1 cm displacement or >45° rotation.
Normal neck shaft angle 130°
Radiological inclusion criteria 3-part fractures:
H + GT, S and LT
H + LT, S and GT
H, LT + GT and S
H, GT, LT + S
H, LT, GT + S
4-part fractures:
H, LT, GT and S
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Outcome measures
Participants will be followed up at 6 weeks, 3 months,
6 months, 1 year, 2 years, 5 years and 10 years. The out-
come measures listed below will be assessed at 6 weeks,
3 months, 6 months, 1 year, 2 years, 5 years and
10 years.
The primary outcome will be the ASES (American
Shoulder and Elbow Society) standardized shoulder as-
sessment score patient self-reported section at 24 months
[27]. This scoring system consists of two dimensions:
pain and activities of daily living, which are both equally
weighted giving a total score out of 100, with higher
scores indicating less pain and better function. It has
been shown to be reliable, valid and responsive in shoul-
der arthroplasty and fracture [28, 29]. Secondary out-
come measures will include DASH (Disability of the
Arm, Shoulder and Hand) score [30], the EQ-5D and
the EQ-VAS, pain (verbal numerical rating scale, 0–10
points), radiological parameters and complications (re-
peat shoulder surgery, readmission, infection requiring
treatment, neurological deficit, dislocation, death). Ra-
diographs will be performed at each follow-up and will
include a four-radiograph series: an AP view in neutral
and 30° external rotation, and a transthoracic scapula
“Y” view and axillary view. Radiographic parameters that
will be assessed are: healing of the tuberosities (non-
union or resorption will be considered failures to heal),
position of the tuberosities, scapula notching (according
to the Sirveaux classification system [31]) and loosening
and alignment (coronal and sagittal plane for patients
treated nonoperatively). All radiographs will be assessed
by two independent observers independently. In case of
discrepancy the scoring will be decided by discussion.
Sample size calculation
Case series documenting the outcome after reverse shoul-
der arthroplasty have shown a standard deviation (SD) of
13 in the ASES score. The minimum important clinical
difference (MICD) in ASES scores has been estimated to
be 6.4–18 [28, 32]. We consider a difference of 10 to be
necessary in order to justify the additional costs and risks
of surgery. A total of 60 patients (30 in each group) will
provide 80% power to detect a MICD of 10 points at a sig-
nificance of 0.05. We aim to recruit 72 patients to allow
for 17% loss to follow-up. The ASES score after reverse
shoulder arthroplasty has been reported to be 68–86
(higher score being better) [33]. In a paper reporting the
outcomes of two-, three- and four-part fractures (our
study proposal is limited to three- and four-part fractures)
treated nonsurgically the mean ASES score was 82.5 [13].
Statistical analysis
Differences in baseline characteristics (i.e., intrinsic and
injury-related variables) between both intervention groups
will be assessed using the Student’ s t test (parametric con-
tinuous data), the Mann-Whitney U test (nonparametric
continuous data) or the chi-square test (categorical data).
Unadjusted analysis by intention-to-treat will be per-
formed to test the difference in primary and secondary
outcomes between the intervention groups. Student’ s t
test (parametric continuous data), the Mann-Whitney U
test (nonparametric continuous data) or the chi-square
analysis (categorical data) will be used. A p value < 0.05
(two-sided tests) will be taken as threshold of statistical
significance.
The observational arm will be analyzed separately,
comparing the same treatment groups against the same
outcomes using multivariable linear regression to adjust
for potential confounders (age, sex, handedness, smok-
ing, fracture type).
Monitoring and quality assurance
Adverse events to be recorded are repeat shoulder
surgery, readmission, infection requiring treatment,
neurological deficit, dislocation and death. All adverse
outcomes will be recorded centrally.
Data will be collected by local site investigators and
study documents will be submitted securely (scanned
and emailed) to the project manager at the administer-
ing institution. Identifying data will be transferred separ-
ately from any study information and stored separately
to the study database. All research documentation will
be labelled with a unique person number as an identifier
and stripped of any potentially identifiable information.
Data will be stored in password-protected computers
and locked filing cabinets as required within the admin-
istering institution
Blinding
Study investigators, surgeons and participants will not
be blinded to the treatment group due to the nature of
the comparators (surgery versus no surgery). The pri-
mary outcome (ASES score) and secondary outcome
scores will be collected by blinded researchers by tele-
phone at all time points. The statistician will be blinded
to the treatment group
Discussion
The optimal treatment of three- and four-part fractures
of the proximal humerus in older people has not yet
been established. Operative treatment in the form of in-
ternal fixation or hemiarthroplasty has not been shown
to be beneficial over nonoperative treatment. The design
of the reverse shoulder arthroplasty has theoretical ad-
vantages in the treatment of these difficult fractures and
several case series have shown good outcomes after re-
verse shoulder arthroplasty. However, there are no pro-
spective RCTs comparing reverse shoulder arthroplasty
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to nonoperative treatment of displaced proximal hu-
meral fractures in older people.
The ReShAPE trial will compare these treatment mo-
dalities and will guide future treatment for this common
injury, potentially changing current practice.
The use of multiple different centers, variability in
selection of surgical technique (approach, version, com-
ponent fixation and prosthesis choice) and an observa-
tional cohort will increase the generalizability of the
results. Randomization will occur only after review of
the scans and after eligibility has been determined;
therefore, making the two groups comparable and redu-
cing selection bias.
Trial status
The ReShAPE trial commenced recruitment in March
2016 but this has not yet been completed.
Additional file
Additional file 1: SPIRIT 2013 Checklist: recommended items to address
in a clinical trial protocol and related documents*. (DOC 121 kb)
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